This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Example of conditiondefinition (id = "example")
<?xml version="1.0" encoding="UTF-8"?> <ConditionDefinition xmlns="http://hl7.org/fhir"> <id value="example"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : example</p> <p> <b> url</b> : <a> http://hl7.org/fhir/ConditionDefinition/example</a> </p> <p> <b> name</b> : Hyperlipidemia</p> <p> <b> title</b> : Hyperlipidemia Status</p> <p> <b> status</b> : draft</p> <p> <b> date</b> : 26 May 2019, 10:44:00 am</p> <p> <b> code</b> : Hyperlipidemia (disorder) <span> (Details : {SNOMED CT code '55822004' = 'Hyperlipidemia', given as 'Hyperlipidemia (disorder)'})</span> </p> <p> <b> hasSeverity</b> : false</p> <p> <b> hasBodySite</b> : false</p> <p> <b> hasStage</b> : false</p> <p> <b> definition</b> : <a> https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a> </p> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Lipid Panel <span> (Details : {LOINC code '24331-1' = 'Lipid 1996 panel - Serum or Plasma', given as 'Lipid 1996 panel - Serum or Plasma'})</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Cholesterol <span> (Details : {LOINC code '35200-5' = 'Cholesterol [Mass or Moles/volume] in Serum or Plasma', given as 'Cholesterol [Moles/​volume] in Serum or Plasma'})</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Triglyceride <span> (Details : {LOINC code '35217-9' = 'Triglyceride [Mass or Moles/volume] in Serum or Plasma', given as 'Triglyceride [Moles/​volume] in Serum or Plasma'})</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Cholesterol in HDL <span> (Details : {LOINC code '2085-9' = 'Cholesterol in HDL [Mass/volume] in Serum or Plasma', given as 'HDL Cholesterol'})</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : LDL Chol. (Calc) <span> (Details : {LOINC code '13457-7' = 'Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation', given as 'Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation'})</span> </p> </blockquote> <h3> Medications</h3> <table> <tr> <td> -</td> <td> <b> Code</b> </td> </tr> <tr> <td> *</td> <td> Gemfibrozil <span> (Details : {RxNorm code '203151' = 'Fenoldopam Mesylate', given as 'Gemfibrozil'})</span> </td> </tr> </table> <h3> Plans</h3> <table> <tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a> http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a> </td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ConditionDefinition/example"/> <name value="Hyperlipidemia"/> <title value="Hyperlipidemia Status"/> <status value="draft"/> <date value="2019-05-26T10:44:00+10:00"/> <code> <coding> <system value="http://snomed.info/sct"/> <code value="55822004"/> <display value="Hyperlipidemia (disorder)"/> </coding> </code> <hasSeverity value="false"/> <hasBodySite value="false"/> <hasStage value="false"/> <definition value="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"/> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="24331-1"/> <display value="Lipid 1996 panel - Serum or Plasma"/> </coding> <text value="Lipid Panel"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35200-5"/> <display value="Cholesterol [Moles/​volume] in Serum or Plasma"/> </coding> <text value="Cholesterol"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35217-9"/> <display value="Triglyceride [Moles/​volume] in Serum or Plasma"/> </coding> <text value="Triglyceride"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="2085-9"/> <display value="HDL Cholesterol"/> </coding> <text value="Cholesterol in HDL"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="13457-7"/> <display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/> </coding> <text value="LDL Chol. (Calc)"/> </code> </observation> <medication> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="203151"/> <display value="Gemfibrozil"/> </coding> </code> </medication> <plan> <reference> <reference value="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"/> </reference> </plan> </ConditionDefinition>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.